Showing 1 to 6 of 6 results


Argentina Charges HLB Pharma Group After Contaminated Fentanyl Kills 68
Argentina filed a criminal complaint against HLB Pharma Group on August 5th, 2025, for allegedly falsifying an import certificate for opiates, leading to contaminated fentanyl that killed 68 people and infected 19 others across various provinces.
Argentina Charges HLB Pharma Group After Contaminated Fentanyl Kills 68
Argentina filed a criminal complaint against HLB Pharma Group on August 5th, 2025, for allegedly falsifying an import certificate for opiates, leading to contaminated fentanyl that killed 68 people and infected 19 others across various provinces.
Progress
48% Bias Score


Counterfeit Weight-Loss Drugs Surge Amidst Soaring Demand
Soaring demand for weight-loss drugs like Wegovy and Ozempic has caused shortages and a surge in counterfeit medications, a global problem estimated by the WHO to affect one in ten drugs, with online pharmacies and compounding practices exacerbating the issue.
Counterfeit Weight-Loss Drugs Surge Amidst Soaring Demand
Soaring demand for weight-loss drugs like Wegovy and Ozempic has caused shortages and a surge in counterfeit medications, a global problem estimated by the WHO to affect one in ten drugs, with online pharmacies and compounding practices exacerbating the issue.
Progress
44% Bias Score


Germany Seeks European Military Protection Amidst US Unpredictability
Amidst concerns over US reliability, German politician Friedrich Merz proposes enhanced military cooperation with France and the UK, potentially including nuclear protection, sparking debate on European defense and Germany's security strategy.
Germany Seeks European Military Protection Amidst US Unpredictability
Amidst concerns over US reliability, German politician Friedrich Merz proposes enhanced military cooperation with France and the UK, potentially including nuclear protection, sparking debate on European defense and Germany's security strategy.
Progress
48% Bias Score

Spain's Ambitious Healthcare Bills Face Political Hurdles
The Spanish Ministry of Health is attempting to pass four significant healthcare bills—tobacco control, alcohol restrictions for minors, pharmaceutical reform, and a healthcare worker statute—despite facing significant political challenges, including a weak parliamentary majority and strong oppositi...

Spain's Ambitious Healthcare Bills Face Political Hurdles
The Spanish Ministry of Health is attempting to pass four significant healthcare bills—tobacco control, alcohol restrictions for minors, pharmaceutical reform, and a healthcare worker statute—despite facing significant political challenges, including a weak parliamentary majority and strong oppositi...
Progress
44% Bias Score

Boehringer CEO Calls for Faster Drug Approvals in Germany
Médard Schoenmaeckers, new Boehringer Ingelheim Germany CEO, criticizes slow drug approvals in Germany compared to the US, citing a three-year delay for a lung cancer drug currently in fast-track approval in the US. He also notes Germany's fall to seventh place globally in clinical trials and calls ...

Boehringer CEO Calls for Faster Drug Approvals in Germany
Médard Schoenmaeckers, new Boehringer Ingelheim Germany CEO, criticizes slow drug approvals in Germany compared to the US, citing a three-year delay for a lung cancer drug currently in fast-track approval in the US. He also notes Germany's fall to seventh place globally in clinical trials and calls ...
Progress
40% Bias Score

FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...

FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...
Progress
24% Bias Score
Showing 1 to 6 of 6 results